These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3948132)

  • 1. Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy.
    Har-El G; Hadar T; Segal K; Levy R; Sidi J
    Cancer; 1986 Apr; 57(8):1613-7. PubMed ID: 3948132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
    Martins RG; Caplan RH; Lambert PJ; Rooney B; Kisken WA
    J Am Coll Surg; 1997 Oct; 185(4):388-97. PubMed ID: 9328388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hürthle cell tumors of the thyroid gland.
    Heppe H; Armin A; Calandra DB; Lawrence AM; Paloyan E
    Surgery; 1985 Dec; 98(6):1162-5. PubMed ID: 4071391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid cancer in patients 70 years of age or older. Retrospective study of 50 patients.
    Har-El G; Sidi J; Kahan E; Segal K; Abraham A
    Ann Otol Rhinol Laryngol; 1987; 96(4):403-10. PubMed ID: 3619285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced thyroid carcinoma: an experience of 385 cases.
    Freschi G; Landi L; Castagnoli A; Taddei A; Bechi P; Bucciarelli G
    Eur J Surg Oncol; 2006 Jun; 32(5):577-82. PubMed ID: 16644177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma.
    Besic N; Hocevar M; Zgajnar J; Petric R; Pilko G
    Thyroid; 2006 Jan; 16(1):67-72. PubMed ID: 16487016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary thyroid carcinoma in an adolescent girl with graves' disease.
    Gesing J; Pfaeffle R; Christiansen H; Keller A; Lincke T; Lamesch P; Sabri O; Kiess W
    Klin Padiatr; 2014 Nov; 226(6-7):379-81. PubMed ID: 25431871
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hürthle cell neoplasms of the thyroid.
    McLeod MK; Thompson NW
    Otolaryngol Clin North Am; 1990 Jun; 23(3):441-52. PubMed ID: 2195433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total thyroidectomy for Hürthle cell neoplasm of the thyroid.
    Gundry SR; Burney RE; Thompson NW; Lloyd R
    Arch Surg; 1983 May; 118(5):529-32. PubMed ID: 6838358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
    Lin JD; Chao TC; Hsueh C
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Limited radical approach in differentiated thyroid gland cancers. A prospective study of 107 patients].
    Engel U; Kucharski A; Zornig C
    Chirurg; 1994 Dec; 65(12):1095-8; discussion 1098-9. PubMed ID: 7851141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hürthle cell carcinoma and "insular" carcinoma: uncommon varieties of thyroid carcinoma].
    Vitali A; Nistri R; Basili G; Carrieri P; Nardi S
    Minerva Chir; 1999 Dec; 54(12):893-8. PubMed ID: 10736995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hürthle cell lesions in thyroid neoplasms.
    Khan MS; al-Manee MS; Huzaimeh IA; Ahmad MS
    Int Surg; 1989; 74(4):261-6. PubMed ID: 2625402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hürthle cell tumors: a twenty-five-year experience.
    Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
    Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hürthle cell lesions of the thyroid gland.
    Thompson NW; Dunn EL; Batsakis JG; Nishiyama RH
    Surg Gynecol Obstet; 1974 Oct; 139(4):555-60. PubMed ID: 4479589
    [No Abstract]   [Full Text] [Related]  

  • 18. Favorable Outcome of Hurthle Cell Carcinoma of the Thyroid Treated With Total Thyroidectomy, Radioiodine, and Selective Use of External-Beam Radiotherapy.
    Zavitsanos P; Amdur RJ; Drew PA; Cusi K; Werning JW; Morris CG
    Am J Clin Oncol; 2017 Aug; 40(4):433-437. PubMed ID: 25730603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.